Awell, the leading CareOps platform, is partnering with Astrana Health Inc. (NASDAQ:ASTH) to scale Awell’s platform across Astrana Health’s network, enhancing patient care, provider experience, and operational efficiency.
Awell empowers clinical and operational teams to design, implement, and improve workflows without IT, enabling providers like Astrana Health to orchestrate over 23 million care activities annually, from patient onboarding to chronic disease management.
The collaboration reflects Awell’s commitment to value-based care and aligns with Astrana Health’s mission to empower providers with advanced technology and clinical tools.
What You Should Know: – KLAS, a leading research and insights firm focusing on healthcare IT, recently released a report exploring the growing adoption and
Recent research explores the impact of hybrid immunity and vaccine-only imprinting on omicron reinfection. Findings suggest effective protection and immune response in a long-term imprinted
TORONTO, July 14, 2023 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) (“Reunion” or the “Company“), a clinical-stage biopharmaceutical company committed to developing
Awell’s CareOps Platform Expands with Astrana Health
by Syed Hamza Sohail Leave a Comment
Generative AI in Healthcare: Accuracy/Reliability Cited Biggest Challenge for Providers, KLAS Reports
What You Should Know: – KLAS, a leading research and insights firm focusing on healthcare IT, recently released a report exploring the growing adoption and
Hybrid immunity and vaccine Imprinting: Powerful defenses against Omicron reinfection
Recent research explores the impact of hybrid immunity and vaccine-only imprinting on omicron reinfection. Findings suggest effective protection and immune response in a long-term imprinted
Reunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of Arrangement – Psychedelic Alpha
TORONTO, July 14, 2023 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) (“Reunion” or the “Company“), a clinical-stage biopharmaceutical company committed to developing